BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 96 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $80,000 | -19.2% | 1,608 | -11.2% | 0.08% | -8.5% |
| Q1 2017 | $99,000 | -47.3% | 1,810 | -46.4% | 0.08% | +6.5% |
| Q4 2016 | $188,000 | -7.8% | 3,380 | -24.1% | 0.08% | -43.4% |
| Q3 2016 | $204,000 | -1.9% | 4,456 | -14.6% | 0.14% | -12.3% |
| Q2 2016 | $208,000 | -30.9% | 5,215 | -39.7% | 0.16% | -25.8% |
| Q1 2016 | $301,000 | – | 8,642 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 82,800 | $2,468,000 | 3.37% |
| NORTHPOINTE CAPITAL LLC | 123,764 | $4,845,000 | 0.52% |
| EAM Investors, LLC | 78,901 | $3,089,000 | 0.36% |
| Elk Creek Partners, LLC | 83,357 | $3,263,000 | 0.34% |
| TFS CAPITAL LLC | 68,551 | $2,684,000 | 0.26% |
| Ativo Capital Management LLC | 13,075 | $512,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 58,623 | $2,295,000 | 0.13% |
| Hillsdale Investment Management Inc. | 10,480 | $410,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 63,647 | $2,492,000 | 0.10% |
| Palo Alto Investors LP | 50,436 | $1,975,000 | 0.10% |